We surveyed over 400 members about what makes healthy eating hard. Our findings helped us create Omada’s nutritional experience that helps members get the support they told us they want when they need it. Learn more in our interview with Sarah Linke, PhD, MPH, Senior Director of Clinical & Translational Research, and Ellery Cook, Senior Director of Product Management. https://buff.ly/hWRCbYb
People rely too much on highly processed food, can’t find time to cook healthy food, or think they don’t know how. Omada’s nutritional experience helps members address the day-to-day obstacles to healthy eating. Learn more in our interview with Sarah Linke, PhD, MPH, Senior Director of Clinical & Translational Research, and Ellery Cook, Senior Director of Product Management. https://buff.ly/hWRCbYb
"With the ACCESS Model, CMS is beginning to imagine and support what care could look like as Gen X ages into Medicare." In a bonus Proof Points to top off 2025, our Chief Privacy and Regulatory Officer, Lucia Savage, shares Omada's actionable recommendations for the Centers for Medicare & Medicaid Services to facilitate a more accessible healthcare ecosystem and help bend the curve of chronic disease. Read it here 👇
High tech 🤝 Human care. Omada’s nutritional experience uses AI tools to support (not replace) the efforts of human-led care teams. Learn more in our interview with Sarah Linke, PhD, MPH, Senior Director of Clinical & Translational Research, and Ellery Cook, Senior Director of Product Management. https://buff.ly/AiK52zy
Ready for a dose of reality? GLP-1 clinical trials are not real life. They are important and necessary for efficacy and FDA approval, but with their optimal circumstances, they can miss the nuances of life that impact the real-world patient experience. To address this gap, Omada Insights Lab spent the past year examining how patients respond to GLP-1s amidst their unique daily challenges and routines. Kevin Masci, Pharm D shares the top outcomes in the video below. Thanks for watching!
Can you believe we’re in the home stretch of 2025? We’ve had a busy year, from the launch of OmadaSpark and Meal Map as part of our nutrition experience, to our debut as a public company, all while serving our thousands members and over 2,000 customers. We’re grateful to each and every one of our partners for helping us bend the curve of chronic disease. In our final Proof Points edition of 2025, Senior Director of Clinical Strategy, Kevin Masci, Pharm D, rounds up Omada Insights Lab’s top research findings of the year, and how they can help scale holistic care for millions of Americans living with cardiometabolic conditions. Read it here 👇 and let us know what else you'd like to learn about GLP-1s and cardiometabolic care.
Real results through-wrap around support 💪 We've supported over 100K+ members since the inception of our GLP-1 Care Track. Proper support can maximize medication persistence and long-term weight maintenance. Learn more about Omada's GLP-1 Care Track: https://lnkd.in/eyr3gZ7k
In honor of #GivingTuesday, our Omada Cares initiative brought colleagues across the country together for meaningful volunteer work: 🗽 New York City team they served breakfast at Bowery Mission 🌾 Twin Cities volunteers packed nutritious meals for children worldwide with Feed My Starving Children 🌱 Bay Area team supported food education and sustainability at Alice Waters' Edible Schoolyard At Omada, we value our community—both in healthcare and beyond. Just as we work to support people on their health journeys, we're committed to positively contributing to the communities where we live and work. Thank you to all our team members who volunteered their time and energy this season.
🌟We believe in the power of human connection in healthcare. Our dedicated care teams - including health coaches, specialists, and physical therapists - provide tailored, 1:1 support for our members. We're thoughtfully integrating AI tools to enhance, not replace, our human-led approach. Gaining efficiencies to help care teams have more productive interactions with members. Investing in our care teams provides better member experiences and high-quality care. Learn more about how we evaluate our programs’ value with the American Medical Association's Return on Health framework: https://lnkd.in/esEpPC66
From skeptic to success story 🌟 Why companion care matters: Our data shows that over 60% of our members maintained or continued to lose weight long after discontinuing GLP-1s—because sustainable outcomes require more than medication alone. Learn more about Omada's GLP-1 Care Track: https://lnkd.in/eyr3gZ7k
